Advanced Health Intelligence (ASX:AHI) EBITDA: A$-7.31 Mil (TTM As of Jun. 2024)


What is Advanced Health Intelligence EBITDA?

Advanced Health Intelligence ASX:AHI EBITDA is A$-7.31 Mil as of Jun. 2024.

Advanced Health Intelligence's EBITDA for the six months ended in Jun. 2024 was A$0.00 Mil. Its EBITDA for the trailing twelve months (TTM) ended in Jun. 2024 was A$-7.31 Mil.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EBITDA Growth Rate using EBITDA data.

Advanced Health Intelligence's EBITDA per Share for the six months ended in Jun. 2024 was A$0.00. Its EBITDA per share for the trailing twelve months (TTM) ended in Jun. 2024 was A$-0.03.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EBITDA per share growth rate using EBITDA per Share data.

Advanced Health Intelligence  (ASX:AHI) EBITDA Explanation

EBITDA is a cash flow measure that ignores changes in working capital. EBITDA minus Depreciation, and Amortization (DA) equals Operating Income. Operating Income is profit before interest and taxes. Of course, Interest and taxes need to be paid.

While depreciation and amortization expenses do not need to be paid in cash, assets - especially tangible assets - do need to be replaced over time. EBITDA is not a measure of profit in any sense. EBITDA is a measure of cash generation by a business where the uses of that cash may be more or less discretionary depending on the nature of the business.

The EBITDA of a TV station is largely discretionary. Owners may use much of the EBITDA generated by a TV station as they see fit. The EBITDA of a railroad is largely non-discretionary. Owners must use much of the EBITDA generated by a railroad to replace the physical assets of the railroad or the business will literally fall apart over time.

EBITDA can be thought of as the cash a business generates that is available to:

Add more inventory
Add more receivables
Replace property, plant, and equipment
Add more property, plant, and equipment
Pay interest
Pay taxes
And finally: pay owners

EBITDA is widely used in financial analysis because Depreciation and Amortization are not present day cash expenses.. Depreciation and amortization are the spreading out of the costs of assets over the time in which those assets provide benefits. Today's depreciation and amortization expenses relate to assets bought in the past. The assets being expensed may or may not need to be replaced in the future. And the cost to replace the assets may be more or less than it was in the past. For this reason, the depreciation and amortization expenses a company records in the present year may have no relationship to the actual cash costs needed to maintain its assets in future years.

A company's depreciation expense depends on both its expectations about the assets it owns and its choice of accounting methods. Two companies owning identical assets may have different depreciation expenses because they have different expectations about the useful lives of those assets and because they make different accounting choices.

Analysts use EBITDA to remove this element of personal choice from a company's accounting statements. The use of EBITDA is an attempt to make the results of different companies more comparable and uniform.


Be Aware

Although depreciation is not a cash cost it is a real business cost because the company has to pay for the fixed assets when they purchase them. Both Warren Buffett and Charlie Munger hate the idea of EBITDA because in this calculation, depreciation is not counted as an expense.

EBITDA over Revenue is a good metric for comparing the operating efficiencies between companies because EBITDA is less vulnerable to companies' accounting choices. For this reason, EBITDA is used in ranking the Predictability of Companies. Also Price-to-EBITDA is sometimes used in valuations.


Advanced Health Intelligence EBITDA Related Terms


Advanced Health Intelligence EBITDA Historical Data

* Premium members only.

The historical data trend for Advanced Health Intelligence's EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Advanced Health Intelligence EBITDA Chart

Advanced Health Intelligence Annual Data
Trend Apr15 Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23 Jun24
EBITDA
Get a 7-Day Free Trial Premium Member Only Premium Member Only -5.67 -14.25 -19.55 -12.04 0.00

Advanced Health Intelligence Semi-Annual Data
Apr15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24
EBITDA Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -3.72 -8.32 -7.31 0.00 0.00

ASX:AHI vs PRST, LAAB, VRTC: EBITDA Comparison

For the Software - Application subindustry, Advanced Health Intelligence's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Advanced Health Intelligence EV-to-EBITDA vs Software Industry

For the Software industry and Technology sector, Advanced Health Intelligence's EV-to-EBITDA distribution charts can be found below:

* The bar in red indicates where Advanced Health Intelligence's EV-to-EBITDA falls into.


Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.

Advanced Health Intelligence's EBITDA for the fiscal year that ended in Jun. 2024 is calculated as

Advanced Health Intelligence's EBITDA for the quarter that ended in Jun. 2024 is calculated as

EBITDA for the trailing twelve months (TTM) ended in Jun. 2024 adds up the semi-annually data reported by the company within the most recent 12 months, which was A$-7.31 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Sometimes companies may have already deducted Depreciation and Amortization from Gross Profit. In this case Depreciation and Amortization needs to be added back when calculating EBITDA.

Frequently Asked Questions Learn more about EBITDA →
What does a EBITDA of A$-7.31 Mil mean?
Advanced Health Intelligence (ASX:AHI) has a EBITDA of A$-7.31 Mil as of Jun. 2024. Ebitda is the difference between operating revenue and operating expenses not including depreciation and amortization. View historical data on Advanced Health Intelligence.
Is Advanced Health Intelligence's EBITDA too high?
Advanced Health Intelligence's current EBITDA is A$-7.31 Mil.
How does Advanced Health Intelligence's EBITDA compare to PRST and LAAB?
Advanced Health Intelligence's EBITDA of A$-7.31 Mil can be compared against companies in the Software industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBITDA for a Software company?
A good EBITDA depends on the Software industry context. However, EBITDA should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBITDA mean?
A high EBITDA can signal that a stock is expensive relative to its fundamentals. Ebitda is the difference between operating revenue and operating expenses not including depreciation and amortization. View historical data on Advanced Health Intelligence. Advanced Health Intelligence's current EBITDA is A$-7.31 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Advanced Health Intelligence stock overvalued right now?
Advanced Health Intelligence (ASX:AHI) has a current EBITDA of A$-7.31 Mil. The current EBITDA is A$-7.31 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBITDA calculated?
EBITDA is calculated from a company's financial statements. For Advanced Health Intelligence (ASX:AHI), the current EBITDA is A$-7.31 Mil as of Jun. 2024. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Advanced Health Intelligence Business Description

Address 71-73 The Esplanade, Unit 5, South Perth, Perth, WA, AUS, 6151
Advanced Health Intelligence Ltd (AHI) is engaged in developing and delivering user-friendly biometric scans to render vital signs and health risk estimates to a smartphone. By leveraging the smartphone with purpose-built computer vision, machine learning models, and patented algorithms, AHI provides a private and secure way for individuals to perform biometric health-risk assessment and stratification. AHI's technology delivers simple-to-use, scalable, and cost-effective means to enable individuals to check, track and act towards better health outcomes. The combination of the patented and proprietary BodyScan dimensioning and composition capabilities and, FaceScan to return vital signs enables a unique health assessment capability made accessible anytime, anywhere through the smartphone.